The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer. [PDF]
Liu X +9 more
europepmc +1 more source
Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis. [PDF]
Mangoni AA, Zinellu A.
europepmc +1 more source
Immunotherapy combined with antiangiogenic therapy as third- or further-line therapy for stage IV non-small cell lung cancer patients with ECOG performance status 2: A retrospective study. [PDF]
Li S +6 more
europepmc +1 more source
Real-world effectiveness and safety of recombinant human endostatin plus PD-1 inhibitors and chemotherapy as first-line treatment for EGFR/ALK-negative, advanced or metastatic non-small cell lung cancer. [PDF]
Zhang J +7 more
europepmc +1 more source
Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring. [PDF]
Gaumond SI +6 more
europepmc +1 more source
Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study. [PDF]
Song JM +8 more
europepmc +1 more source
Structural Insights into Endostatin-Heparan Sulfate Interactions Using Modeling Approaches. [PDF]
Uciechowska-Kaczmarzyk U +3 more
europepmc +1 more source
Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study. [PDF]
Feng Y +6 more
europepmc +1 more source
Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy. [PDF]
Chen K +6 more
europepmc +1 more source
Vascular and Perivascular Role in the Regulation of Angiogenesis: Impact on Arteriovenous Fistula Maturation. [PDF]
Xia F, Rai V, Agrawal DK.
europepmc +1 more source

